Thumbnail Image

Tilapia lake virus disease strategy manual












Tang, K.F.J., Bondad-Reantaso, M.G., Surachetpong, W., Dong, H.T., Fejzic, N., Wang, Q., Wajsbrot, N. & Hao, B. 2021. Tilapia lake virus disease strategy manual. FAO Fisheries and Aquaculture Circular No. 1220. Rome, FAO.




Also available in:
No results found.

Related items

Showing items related by metadata.

  • Thumbnail Image
    Book (stand-alone)
    Shrimp infectious myonecrosis strategy manual 2019
    Also available in:
    No results found.

    This Shrimp infectious myonecrosis strategy manual provides key information for national policy-makers relevant to the development of contingency plans for countries, producers and other stakeholders with regard to outbreaks of infectious myonecrosis (IMN), a viral disease of farmed marine penaeid shrimp that is listed by the World Organisation for Animal Health (OIE). IMN is a viral disease, discovered in 2002, that has caused substantial mortalities in populations of cultured Pacific whiteleg shrimp (Penaeus vannamei) initially reported in Brazil (2002) and Indonesia (2006) and recently in India (2016) and Malaysia (2018). The purpose of this manual is to provide support for the various components of a national contingency plan. The information provided includes: (1) the nature of IMN: providing a brief review of disease etiology, susceptible species and global distribution; (2) diagnosis of infection: describing the gross clinical signs of disease, field diagnostic methods, differential and laboratory methods for diagnosis; (3) prevention and treatment: providing information on vaccination, and resistance and immunity of the hosts; (4) epidemiology: providing information on IMNV’s geographic distribution, persistence in the environment, modes of transmission, vectors and reservoir hosts, factors influencing disease transmission and expression, and impact of the disease; (5) principles of control and eradication: describing the methods and (6) policy development and implementation: summarizing the overall policy, IMN-specific objectives, problems, overview of response options, strategies for eradication and control, capacity building and funding and compensation.
  • Thumbnail Image
    Book (series)
    Shrimp acute hepatopancreatic necrosis disease strategy manual 2020
    Also available in:
    No results found.

    The contents of this Shrimp acute hepatopancreatic necrosis disease strategy manual provides information and guidance relevant to the development of policies to respond to outbreaks of acute hepatopancreatic necrosis disease (AHPND) in farmed marine shrimp. The etiologic agents for AHPND are virulent strains of bacteria belonging to the genus Vibrio parahaemolyticus and related species, which harbor specific toxin genes. While these bacterial species are part of the normal microflora of the marine environment, they may cause substantial mortalities in whiteleg shrimp (Penaeus vannamei) and giant tiger prawn (Penaeus monodon) cultured in countries in Asia and the Americas. These strains of these Vibrio bacteria secrete a PirABvp binary toxin resulting in sloughing of tubule epithelial cells and dysfunctions of the hepatopancreas in the acute form; mortality can reach 100 percent in affected ponds. Chronic presentation of this disease involves secondary bacterial infection of hepatopancreas and running mortality over the culture cycle. Acute or chronic presentation would greatly depend on the culture conditions. This disease can be considered a toxicosis rather than an infection. Economic losses due to this disease have amounted to over USD 7 billion annually. Further outbreaks of AHPND, particularly in areas that are currently free of the disease, would be expected to experience similar devastating effects on local shrimp producers and the surrounding communities; and thus, there is an urgent need to develop a contingency plan to control and eradicate this disease. This manual includes information on: 1) the nature of AHPND: a brief review of current knowledge in disease etiology, susceptible species and global distribution; 2) diagnosis of disease: a description of gross clinical signs and laboratory methods; 3) prevention and treatment: farm management, the use and development of antibiotics, bacteriophages, probiotics, disease-tolerant shrimp, shrimp immunity and vaccination; 4) epidemiology: AHPND’s geographic distribution, genotype, persistence in the environment, reservoir hosts, modes of transmission, risk factors, and economic impacts; 5) principles of control and eradication: methods for containment, mitigation and eradication of AHPND, and trade and industry considerations; and 6) policy development and implementation: AHPND-specific objectives, options and strategies for eradication and control, education, capacity building, funding, and compensation.
  • Thumbnail Image
    Book (stand-alone)
    FAO/WHO/OIE Guidelines for the surveillance, prevention and control of taeniosis/cysticercosis 2005
    Also available in:
    No results found.

    This FAO/WHO/OIE Guidelines for the Surveillance, Prevention and Control of Taenisosis and Cysticercosis is a compilation of the knowledge and valuable expertise of a great many internationally recognized experts on these zoonoses, accumulated over more than a hundred years of research. Without this knowledge base, effective and proven recommendations for diagnosis, treatment, prevention and control would not be possible.

Users also downloaded

Showing related downloaded files

No results found.